Cancer Experimental

Experimental cancer is induced or transplanted cancer in laboratory animals. This type of cancer is used in scientific research to study the mechanisms of development, treatment and prevention of cancer.

Experimental cancer can be caused by a variety of methods, including chemicals, radiation, viruses and other factors. It should be borne in mind that laboratory animals do not have the human immune system, so they may be more sensitive to the effects of these factors.

Transplanted cancer is cancer that has been transplanted from another animal to a laboratory animal. This could be used to study how cancer develops in a new organism, as well as to test new treatments.

Laboratory animals used for experimental cancer research usually have various genetic mutations that allow them to develop more efficiently under experimental conditions. However, it must be taken into account that these animals may have various diseases that may affect the results of the study.

Thus, experimental cancer is an important tool for cancer research and the development of new cancer treatment methods. However, it is necessary to remember the safety and ethical aspects of conducting such studies.

Experimental cancer

Experimental cancer is induced or transplanted cancer tumors in laboratory animals. As a rule, experimental cancer occurs as a result of genetic mutations and disturbances in the mechanisms regulating cell division, which leads to the activation of carcinogenic genes and the transformation of normal cells into malignant ones. Experimental cancer is used to study the processes of occurrence and development of cancer, determine effective treatment methods and predict its course. There are experimental cancers caused by certain chemicals, such as nitrogenous nitrate, the nitrogenous base methyluracin, alkylating agents nodaquindione, propinium bromide, procarbazine, pentostatin and others viruses, such as human papillomavirus (HPV) or sarcoma SV40 ribbons of eukaryotic circular DNA (DNA viruses). Also, cancer in experimental animals can be associated with immunodeficiency states, when the protective forces of the immune system are insufficient. Often, to determine the effectiveness of various drugs, so-called “Oncogenetic screening” is carried out - assessing the effectiveness of treatment at the genetic level. So, for example, when conducting combination chemotherapy for cancer patients, it is recommended that